Enalapril maleate: Difference between revisions

Revision as of 12:15, 7 April 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]

Enalapril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

Adapted from the FDA Package Insert.

@@ Line 5: / Line 5: @@
 {{SB}} VASOTEC in the USA, ENALADEX in some other countries, and ENACARD for veterinary use.
-==Overview==
-Enalapril is an [[angiotensin converting enzyme]] (ACE) inhibitor used in the treatment of [[hypertension]], [[diabetic nephropathy]], and some types of chronic heart failure. [[ACE]] onverts the peptide hormone [[angiotensin I]] to [[angiotensin II]]. One of the actions of angiotensin II is the [[vasoconstriction]] of blood vessels resulting in an increase in [[blood pressure]]. ACE inhibitors such as enalapril prevent this effect. Enalapril has been shown to lower the death rate in systolic [[heart failure]]. Enalapril was the first member of the group known as the dicarboxylate-containing ACE inhibitors.
-==Category==
-Antihypertensive Agents, ACE Inhibitors.
 ==FDA Package Insert==